SequelSEC

NUTRA PHARMA CORP NPHC

Medicinal Chemicals & Botanical Products · CIK 0001119643 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$160.82K
Fiscal year ended 2026-06-30
Operating income
-$1.64M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$702.70KMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.00Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue2.7×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Medicinal Chemicals & Botanical Products filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
FCF margin-461.9%0th
SBC / revenue10.4%100th
Current ratio0.03x4th
Net margin-794.8%5th
Operating margin-567.7%5th
CapEx / revenue10.1%93th
Gross margin76.3%91th
Revenue YoY growth4.6%48th

NUTRA PHARMA CORP (NPHC) reported revenue of $160.82K and net income of -$5.42M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from NUTRA PHARMA CORP’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Medicinal Chemicals & Botanical Products.

Income

NUTRA PHARMA CORP income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$160.82K
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$1.64M
Net income-$5.42M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income-$5.42M
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

NUTRA PHARMA CORP balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalentsUnavailable
Total assets$622.86K
Current assets$463.12K
Total liabilities$21.83M
Current liabilities$21.70M
Total equity incl. NCI-$21.21M
Temporary (mezzanine) equityUnavailable
Inventory$23.51K
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debt$134.81K
Accounts payable$889.62K

Cash flow

NUTRA PHARMA CORP cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$1.05M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$970.53K
Net change in cash-$79.07K
Stock-based compensation$39.83K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

NUTRA PHARMA CORP derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross marginUnavailable
Operating margin-1017.8%
FCF marginUnavailable
SBC / revenue24.8%
Current ratio0.02x
Revenue YoY growth-49.0%
Net margin-3370.6%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open NPHC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-19View SEC filing
10-Q · Filed 2026-05-29View SEC filing
10-K · Filed 2026-05-20View SEC filing
10-Q · Filed 2026-04-06View SEC filing
10-Q · Filed 2026-03-25View SEC filing
10-Q · Filed 2026-03-11View SEC filing

Companies in the same industry

AAWH ADIA AIBT BTMD CBDY CFOO CGC CHUC CRON CYAN DFTX FTLF

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.